MedPath

nani treatment for Heavy Menstrual Bleeding

Phase 2
Conditions
Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
Registration Number
CTRI/2020/02/023357
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1-Women between the ages of 18-40 Years.

2-Regular cycles with heavy bleeding in duration or amount of flow or both.

Exclusion Criteria

Patients with

1-Hb less than 8.5 gm%.

2-H/o systemic diseases and blood dyscrasia.

3-H/o of pelvic pathology and malignancy.

4-H/o of OCPs,IUCD insertion in last 3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in Bleeding <br/ ><br>(amount/ duration)Timepoint: One and half year
Secondary Outcome Measures
NameTimeMethod
Change in <br/ ><br>1-PBAC Score(100) <br/ ><br>2-SF12 scale to assess the QoLTimepoint: One and Half year <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath